We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ANVS market cap is 183.69M. The company's latest EPS is USD -5.4768 and P/E is -3.30.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.68M | -3.17M | -9.97M | -9.76M | -14.86M |
| Net Income | -7.62M | -3.1M | -9.74M | -9.54M | -14.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.61M | -6.64M | -14.54M | -25.51M | -45.04M |
| Net Income | -991k | -5.46M | -14.49M | -25.33M | -56.2M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 32.49M | 36.02M | 25.55M | 22.82M | 10.22M |
| Total Liabilities | 2.53M | 7.7M | 5.41M | 2.07M | 3.57M |
| Total Equity | 29.96M | 28.32M | 20.14M | 20.74M | 6.66M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.12M | 8.12M | 46M | 36.02M | 10.21M |
| Total Liabilities | 2.62M | 578k | 1.51M | 7.7M | 17.96M |
| Total Equity | -8.58M | 7.54M | 44.5M | 28.32M | -7.75M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.7M | -17.31M | -11.63M | -21.23M | -30.6M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 5k | 5k | 7k | 8.58M | 8.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -477k | -3.97M | -9.13M | -17.31M | -39.97M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 444k | 12.04M | 46.74M | 5k | 17.34M |
| Market Cap | 183.69M |
| Price to Earnings Ratio | -3.30 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 32.19 |
| Price to Book Ratio | -23.9 |
| Dividend Yield | - |
| Shares Outstanding | 10.26M |
| Average Volume (1 week) | 317.27k |
| Average Volume (1 Month) | 209.2k |
| 52 Week Change | 23.02% |
| 52 Week High | 22.49 |
| 52 Week Low | 5.42 |
| Spread (Intraday) | 0.59 (3.3%) |
| Company Name | Annovis Bio Inc |
| Address |
1111b s governors avenue dover, delaware 19904 |
| Website | https://www.annovisbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
